RxPONDER-Studie: mehr Klarheit beim Einsatz von Genexpressionstests bei Mammakarzinompatientinnen mit Nodalbefall

Translated title of the contribution: RxPONDER trial: more clarity for use of gene expression assays in node-positive breast cancer patients

M. Banys-Paluchowski*, Peter Paluchowski, Natalia Krawczyk

*Corresponding author for this work
Translated title of the contributionRxPONDER trial: more clarity for use of gene expression assays in node-positive breast cancer patients
Original languageGerman
JournalOnkologe
Volume27
Issue number4
Pages (from-to)378-381
Number of pages4
ISSN0947-8965
DOIs
Publication statusPublished - 04.2021

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

Cite this